A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects

Clinical trial NCT00454233 · COMPLETED

Trial details

NCT number: NCT00454233
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2007-02-01
Primary completion: 2008-06-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.